Log in to save to my catalogue

Association of malignant ascites with systemic inflammation and muscle loss after treatment in advan...

Association of malignant ascites with systemic inflammation and muscle loss after treatment in advan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85e3c33fb8bc439ebe0d402f8e43e288

Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer

About this item

Full title

Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Journal of cachexia, sarcopenia and muscle, 2023-10, Vol.14 (5), p.2114-2125

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Malignant ascites is prevalent in advanced-stage ovarian cancer and may facilitate identification of the drivers of muscle loss. This study aimed to evaluate the association of ascites with changes in systemic inflammation and muscle after treatment of advanced-stage ovarian cancer.
We evaluated 307 patients with advanced-stage (III/IVA) ovarian...

Alternative Titles

Full title

Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_85e3c33fb8bc439ebe0d402f8e43e288

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85e3c33fb8bc439ebe0d402f8e43e288

Other Identifiers

ISSN

2190-5991

E-ISSN

2190-6009

DOI

10.1002/jcsm.13289

How to access this item